In the meantime the Wuhan virus is mutating, creating thousands of different variants. In a recent paper entitled “The impact of viral mutations on recognition by SARS-CoV-2 specific T-cells” is the following figure:
The significance of all this is that the virus is mutating fast enough that vaccines developed for it are likely to have relatively short periods of usefulness. Some of the vaccines create carriers who can transmit the disease asymptomatically, especially the new variants.
Control of the disease will then have to revert to anti-virals, such as ivermectin, and social isolation. There are some antiviral molecules that the virus will not be able to mutate around.
And you don’t want to get this disease. It had been thought that children were somehow immune to the Wuhan virus, but everyone gets damaged by it. Researchers at the Children’s Hospital of Philadelphia have found elevated levels of a biomarker related to blood vessel damage in children with SARS-CoV-2 infection, even if the children had minimal or no symptoms of COVID-19. They also found that a high proportion of children with SARS-CoV-2 infection met clinical and diagnostic criteria for thrombotic microangiopathy (TMA). TMA is a syndrome that involves clotting in the small blood vessels and has been identified as a potential cause for severe manifestations of COVID-19 in adults.
There is also likely to be a long term cancer burden with the Wuhan virus caused by inflammation, just as Hepatitis C results in 20% of those infected developing liver cancer in the disease progression.
With vaccines destined to lose their efficacy, it is time to revisit what cheap antiviral molecules can do. This site has compiled Wuhan virus test results. From that site, this table summarises the data from the “no side effects” molecules in that list:
A combination of these molecules is likely to be good. Ivermectin and iodine have different binding sites on viruses and so are likely to be synergistic. These things are as good as most vaccines and no virus is going to mutate around them. China’s vaccine has less than 50% efficacy by comparison.
The big picture is emerging from the chaos of the last year. Vaccines probably iffy, anti-virals may be the longer term solution, it’s worth making some effort to avoid this disease, and there may be more Chinese bioweapons in the future. Read it all.